Microengineered tumor models: insights & opportunities from a physical sciences-oncology perspective

Peter DelNero1, Young Hye Song1, Claudia Fischbach2,3,4

  • 1Department of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.

Insights

Advanced micro-tumor engineering platforms accurately mimic cancer's complex microenvironment. These tissue engineering and microfabrication systems improve understanding of tumor development and accelerate drug discovery for new cancer therapies.

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Tissue Engineering

Background:

  • The tumor microenvironment significantly influences cancer development and progression.
  • Current limitations in recapitulating tumor physiology hinder therapeutic development.
  • Organotypic culture systems are needed to accurately model cancer pathology.

Purpose of the Study:

  • To review advancements in micro-tumor engineering for modeling cancer.
  • To highlight the role of tissue engineering and microfabrication in creating realistic tumor models.
  • To emphasize the impact on understanding tumor pathogenesis and drug discovery.

Main Methods:

  • Integration of tissue engineering with microfabrication technologies.
  • Development of platforms to control microenvironmental factors (e.g., soluble signals, extracellular matrix, cellular composition).
  • Mimicking tumor heterogeneity and tissue-level phenomena with pathological fidelity.

Main Results:

  • These engineered systems elucidate the role of the microenvironment in cancer.
  • Platforms allow for precise control over spatiotemporal presentation of signals and matrix properties.
  • Improved recapitulation of tumor physiology enhances drug discovery and screening.

Conclusions:

  • Micro-tumor engineering offers a powerful approach to study cancer pathogenesis.
  • These advanced models are crucial for developing targeted therapies, especially those affecting stromal components.
  • Further development in this field promises to significantly impact cancer treatment strategies.